International audienceAims: The recommended first-line treatment for women with gestational diabetes mellitus (GDM) in the case of failure of diet is insulin. Recent results suggest that there is a potential role for glyburide therapy and highlight the need for better knowledge of glycaemic control with glyburide. The objective of this study was to describe and quantify in women with GDM the quality of glycaemic control, including the risk of maternal hypoglycaemia and of therapy failure. Methods: This is a secondary analysis of the French INDAO non-inferiority trial from 2012 to 2016, in which 890 women with GDM randomized to receive glyburide or insulin treatment were compared for perinatal outcomes. Blood glucose concentrations were asse...
Background: Insulin therapy has been the mainstay in managing women with gestational diabetes mellit...
Background: Worldwide, gestational diabetes affects 15% of pregnancies. It is recommended in patient...
Objective: To assess blood glucose control and neonatal outcomes when women with gestational diabete...
International audienceAims: The recommended first-line treatment for women with gestational diabetes...
Background: Several studies have suggested that glibenclamide may be used safely and effectively in ...
Background: Insulin therapy has been the mainstay in managing women with gestational diabetes mellit...
Background: Gestational diabetes mellitus (GDM) has major short- and long-term implications for both...
Insulin is currently the drug of choice in treating patients with gestational diabetes mellitus but ...
Gestational diabetes mellitus compli-cates an estimated 4 % of all preg-nancies and is associated wi...
Objective: To examine the prevalence of antenatal maternal hypoglycemia after initiation of pharmac...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
Background: Gestational diabetes (GDM) represents carbohydrate intolerance first discovered in pregn...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
Background: Gestational diabetes mellitus (GDM) causes adverse pregnancy outcomes that can be averte...
Background: Insulin therapy has been the mainstay in managing women with gestational diabetes mellit...
Background: Worldwide, gestational diabetes affects 15% of pregnancies. It is recommended in patient...
Objective: To assess blood glucose control and neonatal outcomes when women with gestational diabete...
International audienceAims: The recommended first-line treatment for women with gestational diabetes...
Background: Several studies have suggested that glibenclamide may be used safely and effectively in ...
Background: Insulin therapy has been the mainstay in managing women with gestational diabetes mellit...
Background: Gestational diabetes mellitus (GDM) has major short- and long-term implications for both...
Insulin is currently the drug of choice in treating patients with gestational diabetes mellitus but ...
Gestational diabetes mellitus compli-cates an estimated 4 % of all preg-nancies and is associated wi...
Objective: To examine the prevalence of antenatal maternal hypoglycemia after initiation of pharmac...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
Background: Gestational diabetes (GDM) represents carbohydrate intolerance first discovered in pregn...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
International audienceBackground: In pregnant women with gestational diabetes, glyburide can be an a...
Background: Gestational diabetes mellitus (GDM) causes adverse pregnancy outcomes that can be averte...
Background: Insulin therapy has been the mainstay in managing women with gestational diabetes mellit...
Background: Worldwide, gestational diabetes affects 15% of pregnancies. It is recommended in patient...
Objective: To assess blood glucose control and neonatal outcomes when women with gestational diabete...